TR201008517A2 - Pharmaceutical formulation containing olmesartan medoxomil. - Google Patents

Pharmaceutical formulation containing olmesartan medoxomil.

Info

Publication number
TR201008517A2
TR201008517A2 TR2010/08517A TR201008517A TR201008517A2 TR 201008517 A2 TR201008517 A2 TR 201008517A2 TR 2010/08517 A TR2010/08517 A TR 2010/08517A TR 201008517 A TR201008517 A TR 201008517A TR 201008517 A2 TR201008517 A2 TR 201008517A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical formulation
olmesartan medoxomil
formulation containing
containing olmesartan
lubricant
Prior art date
Application number
TR2010/08517A
Other languages
Turkish (tr)
Inventor
Yilmaz Nazli
Uslu Abdullah
Original Assignee
Fargem Farmasöti̇k Araştirma Geli̇şti̇rme Merkezi̇ Sanayi̇ Ve Ti̇caret A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fargem Farmasöti̇k Araştirma Geli̇şti̇rme Merkezi̇ Sanayi̇ Ve Ti̇caret A.Ş. filed Critical Fargem Farmasöti̇k Araştirma Geli̇şti̇rme Merkezi̇ Sanayi̇ Ve Ti̇caret A.Ş.
Priority to TR2010/08517A priority Critical patent/TR201008517A2/en
Publication of TR201008517A2 publication Critical patent/TR201008517A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş konusu ilaç formülasyonu, etken madde olarak olmesartan ve/veya farmasötik açıdan kabul edilebilir bir esterini ya da tuzunu ve kaydırıcı olarak gliseril dibehenatın kullanıldığı en az bir kaydırıcı içermektedir. Etken madde olarak tercihan olmesartan medoksomil kullanılmaktadır.The pharmaceutical formulation of the present invention comprises at least one lubricant using olmesartan and / or a pharmaceutically acceptable ester or salt thereof as the active ingredient and glyceryl dibehenate as the lubricant. Preferably, olmesartan medoxomil is used as the active ingredient.

TR2010/08517A 2010-10-18 2010-10-18 Pharmaceutical formulation containing olmesartan medoxomil. TR201008517A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2010/08517A TR201008517A2 (en) 2010-10-18 2010-10-18 Pharmaceutical formulation containing olmesartan medoxomil.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/08517A TR201008517A2 (en) 2010-10-18 2010-10-18 Pharmaceutical formulation containing olmesartan medoxomil.

Publications (1)

Publication Number Publication Date
TR201008517A2 true TR201008517A2 (en) 2012-05-21

Family

ID=47003383

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/08517A TR201008517A2 (en) 2010-10-18 2010-10-18 Pharmaceutical formulation containing olmesartan medoxomil.

Country Status (1)

Country Link
TR (1) TR201008517A2 (en)

Similar Documents

Publication Publication Date Title
SG10201810985XA (en) Tofacitinib oral sustained release dosage forms
EA201201263A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DAGIGATRAN ETEXYLATE
MA44637B1 (en) Heterocyclic compounds and their uses
EA201390662A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DUTASTERIDE
GB2495676A (en) Use of binders for manufacturing storage stable formulations
EA201300258A1 (en) COMPOSITIONS BASED ON NALBUFIN AND THEIR APPLICATION
EA201270741A1 (en) ORAL COMPOSITIONS AND LIPOPHYL SALTS OF METHylNALTREX
EA201201050A1 (en) PYRAZOLES AS AN ANTAGONISTS CRTH2
CY1115556T1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES DAVIGATRAN
PH12015501096A1 (en) Composition for immediate and extended release
EA201291211A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING HYDROMORPHONE AND NALOXONE
MX344846B (en) Combination of active loaded granules with additional actives.
PH12014502366A1 (en) Injectable formulation
EA201690679A1 (en) STABLE PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPIPIN AND VALSARTAN
TR201010683A1 (en) Vildagliptin formulations.
MX2016001422A (en) Pharmaceutical compositions of fingolimod.
EA201291104A1 (en) ORAL MEDICINAL FORMS BENDAMUSTIN
TR201009394A2 (en) Improved montelukast formulations.
CY1123933T1 (en) LORAZEPAM EXTENDED RELEASE FORMULATIONS
MX346316B (en) Pharmaceutical or neutraceutical formulation.
TR201803451T4 (en) OLMESARTAN FORMULATIONS.
TR201007926A1 (en) Prasugrel tablet formulations.
TR201008517A2 (en) Pharmaceutical formulation containing olmesartan medoxomil.
TR201009399A2 (en) Rapidly soluble effervescent rosuvastatin formulations.
TR201101809A1 (en) Vildagliptin and glimepiride combinations.